222 related articles for article (PubMed ID: 3289183)
1. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
[No Abstract] [Full Text] [Related]
2. Monitoring immunosuppression following renal transplantation.
Giorgi JV; Cosimi AB; Colvin RB; Goldstein G; Delmonico FL; Russell PS
Diagn Immunol; 1983; 1(3):174-8. PubMed ID: 6388969
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies for kidney allograft rejection.
Med Lett Drugs Ther; 1986 Oct; 28(724):97-8. PubMed ID: 3531791
[No Abstract] [Full Text] [Related]
4. [Treatment of refractory acute rejection after renal transplantation with lymphogloline].
Yu LX; Bai XW; Wang JY
Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):348-50. PubMed ID: 7842959
[TBL] [Abstract][Full Text] [Related]
5. OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
Goldstein G; Norman DJ; Shield CF; Kreis H; Burdick J; Flye MW; Rivolta E; Starzl T; Monaco A
Prog Clin Biol Res; 1986; 224():239-49. PubMed ID: 3540993
[No Abstract] [Full Text] [Related]
6. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Monaco A; Goldstein G; Barnes L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
[No Abstract] [Full Text] [Related]
7. Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation.
Burton RC; Cosimi AB; Colvin RB; Rubin RH; Delmonico FL; Goldstein G; Russell PS
J Clin Immunol; 1982 Jul; 2(3 Suppl):142S-147S. PubMed ID: 6290526
[TBL] [Abstract][Full Text] [Related]
8. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary?
Renlund DG; O'Connell JB; Bristow MR
J Heart Transplant; 1989; 8(3):191-3. PubMed ID: 2661767
[No Abstract] [Full Text] [Related]
9. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts.
Alamartine E; Bellakoul R; Berthoux F
Transplant Proc; 1994 Feb; 26(1):273-4. PubMed ID: 8108975
[No Abstract] [Full Text] [Related]
10. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
Kitabayashi K; Munn SR; Sterioff S
Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
[No Abstract] [Full Text] [Related]
11. Definition, diagnosis, and treatment of acute kidney rejection--the first 30 days.
Howard RJ
Transplant Proc; 1986 Apr; 18(2 Suppl 1):92-103. PubMed ID: 2421468
[No Abstract] [Full Text] [Related]
12. Usefulness of CD3 or CD6 anti-T monoclonal antibodies in the treatment of acute corneal graft rejection.
Ippoliti G; Fronterrè A
Transplant Proc; 1989 Feb; 21(1 Pt 3):3133-4. PubMed ID: 2523173
[No Abstract] [Full Text] [Related]
13. [Use of Orthoclone OKT3 in salvage treatment of primary acute renal allograft rejection resistant to steroids and antilymphocyte globulins].
Guérin C; Daoud M; Paysant B; Sabatier JC; Berthoux P; Berthoux F
Nephrologie; 1988; 9(6):282-3. PubMed ID: 3070430
[No Abstract] [Full Text] [Related]
14. Immunosuppression in cardiac transplantation.
Rose EA; Addonizio LJ
Bibl Cardiol; 1988; (43):1-9. PubMed ID: 3067706
[No Abstract] [Full Text] [Related]
15. Comparison of a monoclonal anti-T cell antibody vs ATG as prophylaxis after heart transplantation.
Wollenek G; Laufer G; Laczkovics A; Buxbaum P; Kober I
Transplant Proc; 1989 Feb; 21(1 Pt 3):2499-501. PubMed ID: 2495642
[No Abstract] [Full Text] [Related]
16. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
[No Abstract] [Full Text] [Related]
17. The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin.
Davies SP; Brown EA; Woodrow DF; Phillips ME; Gower PE; Mee AD
Transplantation; 1991 Oct; 52(4):746-9. PubMed ID: 1926361
[No Abstract] [Full Text] [Related]
18. Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibody.
Bach JF; Dardenne M; Chatenoud L
Transplant Proc; 1982 Sep; 14(3):509-12. PubMed ID: 6758237
[No Abstract] [Full Text] [Related]
19. New insights into therapy with monoclonal antibodies in allograft transplantation.
Schena FP
Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
[No Abstract] [Full Text] [Related]
20. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
